
Orchid Pharma Ltd
NSE:ORCHPHARMA

Intrinsic Value
The intrinsic value of one
ORCHPHARMA
stock under the Base Case scenario is
1 175.19
INR.
Compared to the current market price of 789.35 INR,
Orchid Pharma Ltd
is
Undervalued by 33%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Orchid Pharma Ltd
Fundamental Analysis


Revenue & Expenses Breakdown
Orchid Pharma Ltd
Balance Sheet Decomposition
Orchid Pharma Ltd
Current Assets | 8.3B |
Cash & Short-Term Investments | 2.5B |
Receivables | 2.2B |
Other Current Assets | 3.7B |
Non-Current Assets | 8B |
Long-Term Investments | 525.1m |
PP&E | 6.6B |
Intangibles | 185.9m |
Other Non-Current Assets | 745.3m |
Free Cash Flow Analysis
Orchid Pharma Ltd
INR | |
Free Cash Flow | INR |
Earnings Waterfall
Orchid Pharma Ltd
Revenue
|
9B
INR
|
Cost of Revenue
|
-5.3B
INR
|
Gross Profit
|
3.7B
INR
|
Operating Expenses
|
-2.8B
INR
|
Operating Income
|
932.9m
INR
|
Other Expenses
|
262.6m
INR
|
Net Income
|
1.2B
INR
|
ORCHPHARMA Profitability Score
Profitability Due Diligence
Orchid Pharma Ltd's profitability score is 54/100. The higher the profitability score, the more profitable the company is.

Score
Orchid Pharma Ltd's profitability score is 54/100. The higher the profitability score, the more profitable the company is.
ORCHPHARMA Solvency Score
Solvency Due Diligence
Orchid Pharma Ltd's solvency score is 82/100. The higher the solvency score, the more solvent the company is.

Score
Orchid Pharma Ltd's solvency score is 82/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ORCHPHARMA Price Targets Summary
Orchid Pharma Ltd
According to Wall Street analysts, the average 1-year price target for
ORCHPHARMA
is 1 532.72 INR
with a low forecast of 1 105.95 INR and a high forecast of 1 935.15 INR.
Dividends
Current shareholder yield for ORCHPHARMA is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
ORCHPHARMA
stock under the Base Case scenario is
1 175.19
INR.
Compared to the current market price of 789.35 INR,
Orchid Pharma Ltd
is
Undervalued by 33%.